These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31981481)

  • 1. Sprinkling the pixie dust: reflections on innovation and innovators in medicinal chemistry and drug discovery.
    Macdonald SJF; Hatley RJD
    Drug Discov Today; 2020 Mar; 25(3):599-609. PubMed ID: 31981481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal chemistry in drug discovery in big pharma: past, present and future.
    Campbell IB; Macdonald SJF; Procopiou PA
    Drug Discov Today; 2018 Feb; 23(2):219-234. PubMed ID: 29031621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vertical disintegration: a strategy for pharmaceutical businesses in 2009?
    Dixon J; Lawton G; Machin P
    Nat Rev Drug Discov; 2009 Jun; 8(6):435. PubMed ID: 19483701
    [No Abstract]   [Full Text] [Related]  

  • 4. The conformational musings of a medicinal chemist.
    Finch H
    Drug Discov Today; 2014 Mar; 19(3):320-5. PubMed ID: 24184532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embedding sustainable practices into pharmaceutical R&D: what are the challenges?
    Sneddon H
    Future Med Chem; 2014; 6(12):1373-6. PubMed ID: 25329193
    [No Abstract]   [Full Text] [Related]  

  • 6. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry.
    Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A
    Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of discovery chemistry: quo vadis? Academic to industrial--the maturation of medicinal chemistry to chemical biology.
    Hoffmann T; Bishop C
    Drug Discov Today; 2010 Apr; 15(7-8):260-4. PubMed ID: 20149893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New features that improve the pharmacophore tools from Accelrys.
    Sutter J; Li J; Maynard AJ; Goupil A; Luu T; Nadassy K
    Curr Comput Aided Drug Des; 2011 Sep; 7(3):173-80. PubMed ID: 21726193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy.
    Lee JA; Uhlik MT; Moxham CM; Tomandl D; Sall DJ
    J Med Chem; 2012 May; 55(10):4527-38. PubMed ID: 22409666
    [No Abstract]   [Full Text] [Related]  

  • 10. Affairs of the Heart: Innovation in Cardiovascular Research and Development.
    Honig P; Terzic A
    Clin Pharmacol Ther; 2017 Aug; 102(2):162-168. PubMed ID: 28718903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discovery in the next decade: innovation needed ASAP.
    Bennani YL
    Drug Discov Today; 2011 Sep; 16(17-18):779-92. PubMed ID: 21704185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deconstructing the drug development process: the new face of innovation.
    Kaitin KI
    Clin Pharmacol Ther; 2010 Mar; 87(3):356-61. PubMed ID: 20130565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROCK: the Roche medicinal chemistry knowledge application - design, use and impact.
    Mayweg A; Hofer U; Schnider P; Agnetti F; Galley G; Mattei P; Lucas M; Boehm HJ
    Drug Discov Today; 2011 Aug; 16(15-16):691-6. PubMed ID: 21439402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where will we get the next generation of medicinal chemists?
    Allen D
    Drug Discov Today; 2016 May; 21(5):704-6. PubMed ID: 27131748
    [No Abstract]   [Full Text] [Related]  

  • 15. Could pharma open its drug freezers?
    Mullard A
    Nat Rev Drug Discov; 2011 Jun; 10(6):399-400. PubMed ID: 21629278
    [No Abstract]   [Full Text] [Related]  

  • 16. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menelas Pangalos. Interview by Asher Mullard.
    Mullard A
    Nat Rev Drug Discov; 2013 Jun; 12(6):418. PubMed ID: 23722338
    [No Abstract]   [Full Text] [Related]  

  • 19. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.
    Kogej T; Blomberg N; Greasley PJ; Mundt S; Vainio MJ; Schamberger J; Schmidt G; Hüser J
    Drug Discov Today; 2013 Oct; 18(19-20):1014-24. PubMed ID: 23127858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An industrial perspective on the design and development of medicines for older patients.
    Page S; Coupe A; Barrett A
    Int J Pharm; 2016 Oct; 512(2):352-354. PubMed ID: 27001530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.